Concepedia

David Meloni

DM

Statistics

Publications

10

Citations

590

H-Index

10

Active since

1992

Affiliations

Experimental Station(Current)

Incyte (United States)

DuPont (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

David Meloni is an author at Experimental Station specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1992–2011

10

Publications

10

Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist

Robert D. Larsen, Anthony O. King, Cheng‐Yu Chen et al. · The Journal of Organic Chemistry · 1994 · 193 citations

, , +8

Enantioselective Synthesis of Janus Kinase Inhibitor INCB018424 via an Organocatalytic Aza-Michael Reaction

Qiyan Lin, David Meloni, Yongchun Pan et al. · Organic Letters · 2009 · 170 citations

, , +11

Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist

Chu‐Biao Xue, Hao Feng, Ganfeng Cao et al. · ACS Medicinal Chemistry Letters · 2011 · 48 citations · Full text

, , +17

Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist

Chu‐Biao Xue, Anlai Wang, Qi Han et al. · ACS Medicinal Chemistry Letters · 2011 · 46 citations · Full text

, , +9

Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2

Chu‐Biao Xue, Anlai Wang, David Meloni et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 41 citations · Full text

, , +6

1–5 of 10